neuropeptide AF (Human) [5683]
neuropeptide AF (Human)
| SMILES |
CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](C)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](Cc1ccccc1)C(=O)O |
| InChIKey |
YPBGORNZMUQFSF-KWFINLGMSA-N |
| Sequence |
AGEGLNSQFWSLAAPQRF |
| HELM |
PEPTIDE1{A.G.E.G.L.N.S.Q.F.W.S.L.A.A.P.Q.R.F}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
26 |
| Hydrogen bond donors |
27 |
| Rotatable bonds |
61 |
| Log P |
-8.920 |
| Molecular weight (Da) |
1978.0 |
| Stereochemistry info |
unspecified |
No bioactivity data available.
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Endogenous |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.